The top 10 dealmakers at publicly traded private-equity firms took home at least $1.7 billion in dividends in 2013 as they seized on rallying stock markets to sell stakes in everything from a Chinese insurer to a U.S. theme-park operator to a French floormaker.
Forest Laboratories Inc., maker of the Alzheimer’s drug Namenda, will buy Aptalis Pharma for $2.9 billion, adding treatments for gastrointestinal ailments and cystic fibrosis. Forest rose the most in at least 34 years.
A dozen men in black guard the St. Petersburg offices of hypermarket operator Lenta LLC. They’re a reminder of how much muscle it is taking TPG Capital, which owns a stake in the company, to establish a beachhead in Russia.
Greece must default on its sovereign debt, following Argentina’s example, before it can emerge from the crisis now spreading through Europe, TPG Capital co-founder David Bonderman said today at a conference.